|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||235.75 - 240.36|
|52 Week Range||165.75 - 256.62|
|Beta (5Y Monthly)||1.38|
|PE Ratio (TTM)||37.35|
|Earnings Date||Feb 10, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||254.85|
IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IQVIA Holdings Inc. ( NYSE:IQV ) received a lot of attention from a substantial price increase on the NYSE over the...
RESEARCH TRIANGLE PARK, N.C., January 31, 2023--IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the pharmaceutical and broader life sciences industry, today announces the first life sciences industry collaboration with Alibaba Cloud in China. IQVIA and Alibaba Cloud, the digital technology and intelligence backbone of Alibaba Group, will be providing solutions hosted in Mainland China leveraging Salesforce on Alibaba Clou